Medicamen Biotech announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e.
10%) , subject to the approval of the shareholders.
Board of Medicamen Biotech recommends final dividend
Capital Market 3 weeks ago
Dailyhunt
Disclaimer: This content has not been generated, created or edited by Dailyhunt. Publisher: Capital Market